Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes